These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27978944)

  • 21. Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.
    Chen JY; He PC; Liu YH; Wei XB; Jiang L; Guo W; Duan CY; Guo YS; Yu XP; Li J; Li WS; Zhou YL; Lin CY; Luo JF; Yu DQ; Chen ZJ; Chen W; Chen YY; Guo ZQ; Geng QS; Tan N
    JAMA Intern Med; 2019 Feb; 179(2):186-194. PubMed ID: 30592483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
    Kunadian V; Mehran R; Lincoff AM; Feit F; Manoukian SV; Hamon M; Cox DA; Dangas GD; Stone GW
    Am J Cardiol; 2014 Dec; 114(12):1823-9. PubMed ID: 25438908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
    Mega JL; Braunwald E; Murphy SA; Plotnikov AN; Burton P; Kiss RG; Parkhomenko A; Tendera M; Widimsky P; Gibson CM
    J Am Coll Cardiol; 2013 May; 61(18):1853-9. PubMed ID: 23500262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Goto K; Lansky AJ; Nikolsky E; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
    JACC Cardiovasc Interv; 2011 Jul; 4(7):769-77. PubMed ID: 21777885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel.
    Widimsky P; Motovska Z; Bolognese L; Dudek D; Hamm C; Tanguay JF; Ten Berg J; Brown E; LeNarz L; Miller DL; Montalescot G;
    Heart; 2015 Aug; 101(15):1219-24. PubMed ID: 26060122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery.
    Redfors B; He CH; Palmerini T; Caixeta A; Giustino G; Ayele GM; Kirtane AJ; Mehran R; Stone GW; Généreux P
    J Invasive Cardiol; 2017 Feb; 29(2):42-49. PubMed ID: 27974670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    Lopes RD; Alexander KP; Manoukian SV; Bertrand ME; Feit F; White HD; Pollack CV; Hoekstra J; Gersh BJ; Stone GW; Ohman EM
    J Am Coll Cardiol; 2009 Mar; 53(12):1021-30. PubMed ID: 19298914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).
    Lansky AJ; Mehran R; Cristea E; Parise H; Feit F; Ohman EM; White HD; Alexander KP; Bertrand ME; Desmet W; Hamon M; Stone GW
    Am J Cardiol; 2009 May; 103(9):1196-203. PubMed ID: 19406258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).
    Cornel JH; Tricoci P; Lokhnygina Y; Moliterno DJ; Wallentin L; Armstrong PW; Aylward PE; Clare RM; Chen E; Leonardi S; Van de Werf F; White HD; Held C; Strony J; Mahaffey KW; Harrington RA
    Am J Cardiol; 2015 May; 115(10):1325-32. PubMed ID: 25776457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial.
    Généreux P; Bernard S; Palmerini T; Caixeta A; Rosner G; Reiss GR; Xu K; Mehran R; Stone GW;
    EuroIntervention; 2015 Aug; 11(4):399-406. PubMed ID: 25022226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
    Palmerini T; Dangas G; Mehran R; Caixeta A; Généreux P; Fahy MP; Xu K; Cristea E; Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2011 Dec; 4(6):577-84. PubMed ID: 22028471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials.
    Wessler JD; Généreux P; Mehran R; Ayele GM; Brener SJ; McEntegart M; Ben-Yehuda O; Stone GW; Kirtane AJ
    JACC Cardiovasc Interv; 2016 Feb; 9(4):331-337. PubMed ID: 26803422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
    Madhavan MV; Généreux P; Rubin J; Palmerini T; Caixeta A; Xu K; Weisz G; Mehran R; Stone GW
    Am J Cardiol; 2014 Apr; 113(8):1331-7. PubMed ID: 24560063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus delayed, provisional eptifibatide in acute coronary syndromes.
    Giugliano RP; White JA; Bode C; Armstrong PW; Montalescot G; Lewis BS; van 't Hof A; Berdan LG; Lee KL; Strony JT; Hildemann S; Veltri E; Van de Werf F; Braunwald E; Harrington RA; Califf RM; Newby LK;
    N Engl J Med; 2009 May; 360(21):2176-90. PubMed ID: 19332455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
    Stone GW; Clayton T; Deliargyris EN; Prats J; Mehran R; Pocock SJ
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):15-20. PubMed ID: 24140664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial.
    Yan AT; Yan RT; Huynh T; DeYoung P; Weeks A; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2008 Oct; 156(4):769-75. PubMed ID: 18926160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    McEntegart MB; Kirtane AJ; Cristea E; Brener S; Mehran R; Fahy M; Moses JW; Stone GW
    J Am Coll Cardiol; 2012 May; 59(20):1745-51. PubMed ID: 22575311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.